Agomab Therapeutics
Series BAgomab Therapeutics raised €41M in a Series B round in Jul 2022. The company is based in Ghent, Belgium. Investors in the round: Pfizer Ventures, Sabadell Asabys, Walleye Capital. Data as of Nov 2026.
Amount raised
€41M
€40,500,000
Native amount
40,500,000 EUR
Stage
Series B
series b
Investors
3
Provenance & confidence
High confidenceAmount
Reported in EUR — no conversion. €41M
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
3 namedDate
Jul 2022
Round type
series b
Amount (EUR)
€41M